Assistant Clinical Professor of Medicine, Hematology-Oncology
Dr. Chmielowski trained at the Akademia Medyczna in Wroclaw, Poland. After graduation, Dr. Chmielowski concentrated on the laboratory research in the Institute of Molecular Medicine and Genetics at Medical College of Georgia in August, Georgia. His research concentrated on mechanisms regulating the development of T lymphocytes in the thymus, in particular, processes of positive and negative selection. This research has become a base for his Ph.D. dissertation, entitled “The Influence of a Single MHC Class II Complex with Covalently Bound Peptide on Positive Selection of T Cells in the Thymus” (2002).
At UCLA, Dr. Chmielowski has been conducting studies on understanding the molecular aberrations and on development of new therapies in melanoma. He has a special interest in immunotherapy and targeted therapy with small molecules and monoclonal antibodies. He is also actively involved in multiple clinical trials in patients with melanoma and sarcoma.